Edinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
Transpl Int. 2022 Jun 3;35:10493. doi: 10.3389/ti.2022.10493. eCollection 2022.
Normothermic Regional Perfusion (NRP) has shown encouraging clinical results. However, translation from an experimental to routine procedure poses several challenges. Herein we describe a model that led to the implementation of NRP into standard clinical practice in our centre following an iterative process of refinement incorporating training, staffing and operative techniques. Using this approach we achieved a four-fold increase in trained surgical staff and a 6-fold increase in competent senior organ preservation practitioners in 12 months, covering 93% of the retrieval calls. We now routinely provide NRP throughout the UK and attended 186 NRP retrievals from which 225 kidneys, 26 pancreases and 61 livers have been transplanted, including 5 that were initially declined by all UK transplant centres. The 61 DCD(NRP) liver transplants undertaken exhibited no primary non-function or ischaemic cholangiopathy with up to 8 years of follow-up. This approach also enabled successful implementation of ex situ normothermic liver perfusion which together with NRP contributed 37.5% of liver transplant activity in 2021. Perfusion technologies ( and ) are now supported by a team of Advanced Perfusion and Organ Preservation Specialists. The introduction of novel perfusion technologies into routine clinical practice presents significant challenges but can be greatly facilitated by developing a specific role of Advanced Perfusion and Organ Preservation Specialist supported by a robust education, training and recruitment programme.
常温区域灌注(NRP)已显示出令人鼓舞的临床效果。然而,将实验方法转化为常规程序存在一些挑战。在此,我们描述了一种模型,通过不断完善培训、人员配备和手术技术,使 NRP 在我们中心从实验方法转化为常规临床实践。通过这种方法,我们在 12 个月内培训了 4 倍的外科手术人员,并培养了 6 倍的有能力的高级器官保存专家,覆盖了 93%的检索需求。现在我们在英国各地常规提供 NRP,并参与了 186 次 NRP 检索,其中移植了 225 个肾脏、26 个胰腺和 61 个肝脏,包括最初被所有英国移植中心拒绝的 5 个。进行的 61 例 DCD(NRP)肝移植没有原发性无功能或缺血性胆管炎,随访时间长达 8 年。这种方法还实现了离体常温肝灌注的成功实施,与 NRP 一起,2021 年贡献了 37.5%的肝移植活动。灌注技术( 和 )现在得到了一组高级灌注和器官保存专家的支持。将新型灌注技术引入常规临床实践存在重大挑战,但通过开发高级灌注和器官保存专家的特定角色,并辅以强大的教育、培训和招聘计划,可以大大促进其发展。